Will Ozempic be ranked within the top three prescribed drugs for diabetes by June 30, 2024?
14
94
Ṁ14KṀ1.8K
Jun 21
3%
chance
1D
1W
1M
ALL
This market resolves to 'yes' if market reports or pharmaceutical tracking studies published by IQVIA, the National Prescription Audit (NPA), or the Centers for Medicare & Medicaid Services (CMS) before or on June 30, 2024, rank Ozempic among the top three prescribed drugs for diabetes. The resolution source will be the publicly available reports from these specified organizations. The market end date is June 30, 2024.
Get Ṁ200 play money
Related questions
Is Ozempic an effective anti-addiction drug? (My credence in a year)
63% chance
Will a warning label regarding potential suicide risks be added to Ozempic's labeling by June 30, 2024?
21% chance
Will Pfizer announce a weight loss drug competing with Ozempic and Wygovy before 12/31/2024?
39% chance
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
31% chance
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
68% chance
The FDA will warn about overuse or misuse of semaglutide (Ozempic, Wegovy and Rybelsus) before the end of 2024.
33% chance
How much will Ozempic cost in 2027 in the USA?
Will there be a recall of Wegovy/Ozempic before 2035?
45% chance
Will Type 1 Diabetes be cured by the end of 2040?
41% chance
Will 10 million Americans be on semaglutide (or yet-to-be-approved equally good or superior alternatives) by the end of 2030?
73% chance